Literature DB >> 18375641

Two cases of valproic acid poisoning treated with L-carnitine.

Y C Chan1, M L Tse, F L Lau.   

Abstract

Two cases of acute valproic acid poisoning with central nervous system depression and raised ammonia level without hepatotoxicity were reported. They were treated successfully with the use of the antidotes: L-carnitine and other supportive measures. Clinical manifestation and progress was described, and discussion is focused on the use of L-carnitine in valproic acid-induced hyperammonemia, from its mechanism to the clinical experiences in the literature. Based on the favorable response of our two cases and the literature review, we recommend the administration of intravenous L-carnitine in patients of valproic acid overdose with hyperammonemia or valproic acid-induced hyperammonemic encephalopathy and hepatotoxicity at a dose of 50 mg/kg every 8 h for the first initial 24 h with further individual assessment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18375641     DOI: 10.1177/0960327107087799

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

Review 2.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

3.  Acute liver impairment after sodium valproate overdose.

Authors:  William Stephen Waring; Andrew C Nixon
Journal:  BMJ Case Rep       Date:  2009-05-11

4.  Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid.

Authors:  Illora A Darbar; Paulo G Plaggert; Maria Bernadete D Resende; Edmar Zanoteli; Umbertina C Reed
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

5.  Favorable results after conservative management of 316 valproate intoxicated patients.

Authors:  Shahin Shadnia; Hasan Amiri; Hossein Hassanian-Moghaddam; Mahdi Rezai; Zohreh Vasei; Nillofar Ghodrati; Nasim Zamani
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

6.  Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.

Authors:  Hao Niu; Edmond Atallah; Ismael Alvarez-Alvarez; Raul J Andrade; M Isabel Lucena; Inmaculada Medina-Caliz; Guruprasad P Aithal; Cigdem Arikan
Journal:  Drug Saf       Date:  2022-08-25       Impact factor: 5.228

7.  Posterior reversible encephalopathy syndrome in a survivor of valproate-induced acute liver failure: a case report.

Authors:  Sachith Mettananda; Asvini D Fernando; Nimasari Ginige
Journal:  J Med Case Rep       Date:  2013-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.